openPR Logo
Press release

Global Hunter Syndrome Treatment Market Size, Industry Share, Growth & Forecast To 2025

06-10-2020 04:13 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Research

The global hunter syndrome treatment market is estimated to witness significant growth during the forecast period. Innovative novel therapies in clinical trials and increasing R&D activities by major market players for the development of hunter syndrome treatment are the major two driving factors that are propelling the global hunter syndrome treatment market.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/hunter-syndrome-treatment-market

A Full Report of Global Hunter Syndrome Treatment Market is Available at:https://www.omrglobal.com/industry-reports/hunter-syndrome-treatment-market

Few Recent Innovations in The Market-

In December 2019, Regenxbio’s R&D on gene therapy RGX-121 showed a positive action in the hunter syndrome treatment study. In this study, the company found this gene therapy can decline high levels of heparan sulfate which are associated with neurocognitive by 33% from baseline to week 8. Also, this study found that those patients who progressed beyond week 24 showed stable neurocognitive development. The estimated completion date of this R&D study is December 2022.
In November 2019, Bioasis announced the allowance of patent applications of xB3 platform in Japan, later in 2020, it allowed patent applications in the US and Europe.
In June 2019, Denali Therapeutics got approval from the US FDA for DNL310, it is an enzyme replacement therapy for patients with Hunter syndrome.
In August 2018, ArmaGen received the US Orphan Drug Designation for AGT-184. It is an investigational enzyme replacement therapy (ERT) for the treatment of hunter syndrome treatment. In December 2019, Regenxbio’s R&D on gene therapy RGX-121 showed a positive action in the hunter syndrome treatment study. In this study, the company found this gene therapy can decline high levels of heparan sulfate which are associated with neurocognitive by 33% from baseline to week 8. Also, this study found that those patients who progressed beyond week 24 showed stable neurocognitive development. The estimated completion date of this R&D study is December 2022.
In February 2018, Inventive announced it shows a positive outcome of biomarker study measuring intracellular GAGs in leukocytes from MPS VI patients. This R&D is intended to reduce leukoGAGs enzymes using MPS VI and limited ERT.

Global Hunter Syndrome Treatment Market Segmentation

By Treatment

Enzyme Replacement Therapy (ERT)
Hematopoietic Stem Cell Transplant (HSCT)
Others (Gene Therapy, Bone Marrow Transplant, Tonsillectomy)

Global Hunter Syndrome Treatment Market – Segment by Region

North America

US
Canada

Europe

Germany
UK
France
Spain
Italy
Rest of Europe

Asia-Pacific

China
Japan
India
Rest of Asia-Pacific

Rest of the World

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/hunter-syndrome-treatment-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Hunter Syndrome Treatment Market Size, Industry Share, Growth & Forecast To 2025 here

News-ID: 2071752 • Views: 157

More Releases from Orion Market Research

Emergency Medical Services Market Size, Share, Industry Growth, Analysis and For …
The global emergency medical services market is anticipated to grow at a considerable CAGR of 5.5% during the forecast period. As there are advancements in technology such as various software developments and others owing to their high technologies the majority of healthcare professionals opt for these services widely. Healthcare professionals are more influenced and attracted towards high integrated quick and mobile response branches of the wider and broader healthcare system,
Rabies Immunoglobulin Market Growth, Share, Trends and Overview 2023-2029
The global rabies immunoglobulin market is anticipated to grow at a CAGR of 6.1% during the forecast period. As a zoonotic disease, it requires close cross-sectoral coordination at the national, regional, and global levels. The rising government initiatives in the market are expected to surge the market growth during the forecast period. Rabies is included in WHO's new 2021-2030 road map. The 2030 NTD Roadmap is a guiding document for
Central Nervous System Therapeutic Market Trends, Size, Share and Forecast 2023- …
The global central nervous therapeutics market is expected to grow at a CAGR of 7.5% during the forecast period. The growing number of central nervous disorders across the globe is significantly contributing to the growth of the global central nervous system therapeutic market. The prevalence of Alzheimer's disease, multiple sclerosis, epilepsy, Parkinson's disease, mental health and stroke are significantly growing across the globe. For instance, as per the World Health
Enteric Disease Testing Market Trends, Size, Share and Forecast 2023-2029
The global enteric disease testing market is anticipated to grow at a CAGR of 3.2% during the forecast period. The increasing prevalence of enteric disease infections with a lack of proper sanitation is significantly contributing to the growth of the enteric disease testing market. According to the World Health Organization (WHO), salmonella is one of the major causes of diarrhoeal diseases across the globe. Due to the consumption of unsafe

All 5 Releases


More Releases for R&D

Siveco doubles China R&D investment
On July 3, 2019, Siveco China held its half-year management meeting at the prestigious Hellas House in Shanghai, a nod to the company's continuing growth on the Belt & Road. With financial results above target, high customer satisfaction (as shown in the latest audited customer satisfaction survey) and a sales pipeline more promising than ever, the company's management board announced that shareholders have approved its request for additional investment in
R&D Collaborative Projects by GD Rectifiers
GD Rectifiers have extensive experience in collaborative R&D projects and are proud to work with some of the UK’s pioneering power electronic companies to drive design and innovation forward. This R&D service helps drive GD Rectifiers forward as a cutting edge manufacturer embracing fundamental technologies that support product development that contribute to next generation products throughout: renewable energy, embedded systems, smart metrering and the rail industry. Power Assemblies, Controllers and
Transforming Pharmaceutical R&D with Data
ReportsWorldwide has announced the addition of a new report title Transforming Pharmaceutical R&D with Data to its growing collection of premium market research reports. Transforming Pharmaceutical R&D with Data In the current drug pricing environment, biopharmaceutical firms cannot afford to continue spending billions of dollars on development programs that are more than 90% likely to fail. Raising prices to compensate for expensive, risky research and development (R&D) is no longer an option
Noliac is expanding the R&D team
Noliac is looking for two new colleagues for the R&D team in Prague, Czech Republic: A Precision/Fine Mechanics and an Electroengineer. Precision/Fine Mechanics For the R&D team in Prague, Czech Republic, Noliac is looking for a Precision/Fine mechanics to work on modifying existing products and work with developing new. Noliac requires a colleague who: Is mechanically skilled with a focus on very small machinery. Holds a technical high school degree or an apprenticeship
Leiber GmbH further invests in R&D
Since February 2016, Leiber GmbH has been reinforced by Dr med vet Claudia Westfahl - a veterinarian specialized in animal nutrition - as part of the company's strategy to invest in new product developments. With the new position ‘Product Development Animal Nutrition’, Dr Westfahl is responsible for new product development in the field of functional feed ingredients for both pet as well as farm animals. After graduating at the University
Rising R&D Funding for Nanotechnology
Global nanotechnology market has been registering marked increase in funds allocation by the countries across the world, especially with new product development that received huge momentum due to these funding. An increase in global public funding for R&D initiatives supports quick commercialization of nano-based products. Fundings from governments, corporations, and venture capital exhibited a CAGR growth of 1% during 2008-2012. In future, it is expected that nanotechnology funding will grow